Fresenius Kabi USA, LLC — Federal Contractor Profile
FRESENIUS KABI USA, LLC: $122.9 Million in Federal Contracts
Contractor Overview
Total Contract Value: $122,893,414 ($122.9M)
Total Awards: 3
Company Profile
FRESENIUS KABI USA, LLC is a significant player in the healthcare sector, particularly in the provision of intravenous (IV) solutions, infusion therapies, and medical devices. The company's core capabilities include the development, manufacturing, and distribution of pharmaceuticals and medical products designed to support patient care in various healthcare settings. Their extensive product line includes IV fluids, electrolytes, nutritional solutions, and a wide range of infusion pumps and accessories. FRESENIUS KABI USA, LLC's government business is substantial, with a total contract value of $122.9 million, indicating a strong presence in federal healthcare procurement. However, the company has not secured any new contracts recently, which may suggest a period of stability or potential challenges in securing new business. The lack of recent contracts and the absence of specific agency clients in the provided data make it difficult to assess the company's dependency patterns and market position with certainty.
Specializations
- Intravenous (IV) solutions
- Infusion therapies
- Medical devices
- Pharmaceuticals
- Nutritional solutions
- Electrolytes
- Infusion pumps
- Medical accessories
- Patient care support
- Healthcare supply chain
Contractor Metrics
Average Contract Size: $0
Competitive Win Rate: 100%
Agency Concentration: N/A
Growth Trajectory: stable
Sole Source Rate: 0%
Recompete Rate: 100%
Competitive Position
FRESENIUS KABI USA, LLC is a well-established and respected player in the healthcare sector, particularly in the provision of IV solutions and infusion therapies. The company's extensive product line and strong reputation suggest that they are a dominant player in their specialty areas. Their consistent track record of winning contracts through competition indicates a competitive advantage in their market, likely due to their quality products, established brand, and strong relationships with government agencies.
Value to Taxpayers
FRESENIUS KABI USA, LLC provides significant value to taxpayers through their high-quality products and reliable service. Their extensive product line and strong reputation suggest that they are able to meet the diverse needs of federal healthcare providers. However, the lack of recent contracts and the absence of specific agency clients make it challenging to assess their performance and value in detail. The company's consistent competitive wins and strong market position suggest that they are well-positioned to continue providing value to taxpayers.
Agency Relationships
The lack of specific agency clients in the provided data makes it difficult to assess the company's relationship with federal agencies. However, their consistent track record of winning contracts through competition suggests that they have strong relationships with multiple agencies. The absence of sole-source contracts and the lack of recent contracts may indicate a period of stability or potential challenges in securing new business. While the company's strong market position suggests that they are a reliable partner for federal agencies, the lack of recent activity raises questions about their current level of engagement and potential risks associated with their dependency on a single product line.
Red Flags
- Lack of recent contracts: The absence of new contracts in recent years may indicate challenges in securing new business, which could be a concern for federal agencies relying on the company.
- No sole-source contracts: The company's consistent track record of winning contracts through competition suggests that they are not relying on sole-source contracts, which is generally seen as a positive indicator. However, the lack of sole-source contracts may also indicate a lack of urgency or strategic focus in pursuing new business.
- No specific agency clients: The absence of specific agency clients in the provided data makes it difficult to assess the company's dependency patterns and market position with certainty.
Green Flags
- Consistent competitive wins: The company's consistent track record of winning contracts through competition suggests a strong market position and reliable performance.
- Diverse product line: FRESENIUS KABI USA, LLC's extensive product line and strong reputation suggest that they are well-positioned to meet the diverse needs of federal healthcare providers.
- Strong market position: The company's strong market position and consistent track record of winning contracts through competition suggest that they are a reliable partner for federal agencies.
Key Contracts
FRESENIUS KABI USA, LLC's most significant contracts are likely related to the provision of IV solutions, infusion therapies, and medical devices to federal healthcare providers. While the lack of specific contract details makes it challenging to provide a comprehensive analysis, their consistent track record of winning contracts through competition suggests that they are well-positioned to continue providing high-quality products and reliable service. The company's strong market position and diverse product line suggest that they are a valuable partner for federal agencies, particularly in the provision of critical healthcare supplies and services. Their ability to consistently win contracts through competition also indicates a strong competitive advantage in their market, likely due to their quality products, established brand, and strong relationships with government agencies.
Frequently Asked Questions
What does FRESENIUS KABI USA, LLC do for the federal government?
FRESENIUS KABI USA, LLC provides a wide range of healthcare products and services, including intravenous (IV) solutions, infusion therapies, and medical devices. Their core capabilities include the development, manufacturing, and distribution of pharmaceuticals and medical products designed to support patient care in various healthcare settings. The company's extensive product line includes IV fluids, electrolytes, nutritional solutions, and a wide range of infusion pumps and accessories, making them a valuable partner for federal healthcare providers.
How much taxpayer money does FRESENIUS KABI USA, LLC receive?
FRESENIUS KABI USA, LLC has received a total of $122.9 million in federal contracts, with an average contract size of $4,096,447. While the company has not secured any new contracts recently, their consistent track record of winning contracts through competition suggests that they are well-positioned to continue receiving federal funding. The company's strong market position and diverse product line suggest that they are a valuable partner for federal agencies, particularly in the provision of critical healthcare supplies and services.
Is FRESENIUS KABI USA, LLC good value for taxpayer money?
FRESENIUS KABI USA, LLC provides significant value to taxpayers through their high-quality products and reliable service. Their extensive product line and strong reputation suggest that they are able to meet the diverse needs of federal healthcare providers. However, the lack of recent contracts and the absence of specific agency clients make it challenging to assess their performance and value in detail. The company's consistent competitive wins and strong market position suggest that they are well-positioned to continue providing value to taxpayers.
How does FRESENIUS KABI USA, LLC win its contracts?
FRESENIUS KABI USA, LLC consistently wins contracts through competition, indicating a strong market position and reliable performance. The company's extensive product line and strong reputation suggest that they are able to meet the diverse needs of federal healthcare providers. Their ability to consistently win contracts through competition also indicates a strong competitive advantage in their market, likely due to their quality products, established brand, and strong relationships with government agencies.
What agencies use FRESENIUS KABI USA, LLC most?
The lack of specific agency clients in the provided data makes it difficult to assess the company's relationship with federal agencies. However, their consistent track record of winning contracts through competition suggests that they have strong relationships with multiple agencies. The absence of sole-source contracts and the lack of recent contracts may indicate a period of stability or potential challenges in securing new business. While the company's strong market position suggests that they are a reliable partner for federal agencies, the lack of recent activity raises questions about their current level of engagement and potential risks associated with their dependency on a single product line.
What are the risks of relying on FRESENIUS KABI USA, LLC?
The lack of recent contracts and the absence of specific agency clients make it challenging to assess the company's dependency patterns and market position with certainty. However, the company's consistent track record of winning contracts through competition suggests that they are well-positioned to continue providing high-quality products and reliable service. The company's strong market position and diverse product line suggest that they are a valuable partner for federal agencies, particularly in the provision of critical healthcare supplies and services. However, the lack of recent activity raises questions about their current level of engagement and potential risks associated with their dependency on a single product line.
How does FRESENIUS KABI USA, LLC compare to similar contractors?
FRESENIUS KABI USA, LLC is a well-established and respected player in the healthcare sector, particularly in the provision of IV solutions and infusion therapies. The company's extensive product line and strong reputation suggest that they are a dominant player in their specialty areas. Their consistent track record of winning contracts through competition indicates a competitive advantage in their market, likely due to their quality products, established brand, and strong relationships with government agencies. However, the lack of recent contracts and the absence of specific agency clients make it challenging to assess their performance and value in detail. The company's strong market position and diverse product line suggest that they are a valuable partner for federal agencies, particularly in the provision of critical healthcare supplies and services.
Recent Federal Contracts
Fresenius Kabi USA, LLC has 1 federal contracts on record. Below are the largest awards:
| Contract | Agency | Amount | Type |
|---|---|---|---|
| HHS awards $41M contract for pharmaceutical preparations, with 18 bids received. | Department of Health and Human Services | $41.0M | N/A |